Specialized Medical Expertise Arlington Skin Surgery is led by Dr. Charles Kennard, a highly trained Mohs surgeon with academic and clinical recognition, indicating a focus on advanced dermatological procedures and a potential need for specialized medical supplies, technology, and training solutions tailored to high-precision dermatology surgery.

Growth in Revenue Range With annual revenues between 1 million and 10 million dollars, Arlington Skin Surgery demonstrates a stable financial position that may support investments in new medical technologies, marketing efforts, or expanding service offerings, presenting opportunities for partners offering value-added solutions.

Targeted Market Niche Focusing on skin cancer removal through Mohs surgery positions the company within a niche market with increasing demand due to rising skin cancer rates, creating sales opportunities in diagnostic tools, surgical equipment, and patient management systems tailored to dermatology practices.

Tech Infrastructure The company's website utilizes various modern web technologies such as WordPress and Google Fonts API, indicating a digital presence that could benefit from enhanced cybersecurity, patient engagement platforms, or online marketing solutions aimed at increasing patient outreach and appointments.

Industry Competitors As a small but specialized practice with similar firms and notable competitors, Arlington Skin Surgery may be receptive to value propositions that improve operational efficiency, staff training, or clinical outcomes, opening opportunities for innovative medical devices and practice management tools.